Find clinical trials for Non-Hodgkin Lymphoma in Durham, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Durham, NC, USA:
Targeted drug therapies have greatly improved outcomes for patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and non...
Phase 2
Durham, North Carolina, United States and 7 other locations
This study has 2 parts.The main aim of Part 1 is to check for side effects from TAK-007 in adults with relapsed or refractory (r/r) B-cell Non...
Phase 2
Durham, North Carolina, United States and 14 other locations
This is a Phase 1/1b, nonrandomized, open-label, parallel assignment, dose-escalation, and dose-expansion study to evaluate the safety and clinical a...
Phase 1
Durham, North Carolina, United States and 20 other locations
evaluate the efficacy, safety, and tolerability BGB-3111 plus obinutuzumab versus obinutuzumab alone in participants with relapsed/refractory non...
Phase 2
Durham, North Carolina, United States and 83 other locations
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX110 in subjects with relapsed or refractory B-cell malig...
Phase 1, Phase 2
Durham, North Carolina, United States and 32 other locations
This is an open-label, multi-center Phase 1/2 study of oral LOXO-305 (pirtobrutinib) in patients with CLL/SLL and NHL who have failed or are intolera...
Phase 1, Phase 2
Durham, North Carolina, United States and 55 other locations
DS-3201b is an experimental drug that is being investigated in clinical research.Adults with non-Hodgkin lymphoma (NHL) ma...
Phase 1
Durham, North Carolina, United States and 20 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....
Phase 3
Chapel Hill, North Carolina, United States and 136 other locations
The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...
Phase 3
Durham, North Carolina, United States and 142 other locations
safety, and pharmacokinetics of zamtocabtagene autoleucel (MB-CART2019.1) in patients with relapsed and/or refractory diffuse large B cell lymphoma...
Phase 2
Durham, North Carolina, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal